CTKB - Cytek Biosciences, Inc.
IEX Last Trade
6.305
-0.025 -0.397%
Share volume: 2,110
Last Updated: Fri 27 Dec 2024 05:30:43 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.45%
PREVIOUS CLOSE
CHG
CHG%
$6.33
-0.03
-0.39%
Fundamental analysis
12%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
10%
Performance
5 Days
0.46%
1 Month
1.25%
3 Months
24.81%
6 Months
22.45%
1 Year
-31.61%
2 Year
-35.87%
Key data
Stock price
$6.30
DAY RANGE
$6.27 - $6.62
52 WEEK RANGE
$4.88 - $9.49
52 WEEK CHANGE
-$31.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Wen B. Jiang
Region: US
Website: cytekbio.com
Employees: 500
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: cytekbio.com
Employees: 500
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.
Recent news